Shoujaa Ahmad, Mukhalalaty Yasser, Murad Hossam, Al-Quobaili Faizeh
Faculty of Pharmacy, Damascus University, Damascus, Syria.
Thalassaemia Centre, Ministry of Health, Damascus, Syria.
Hemoglobin. 2019 Jul-Sep;43(4-5):283-285. doi: 10.1080/03630269.2019.1670206. Epub 2019 Nov 12.
β-Thalassemia (β-thal) is a hereditary and heterogeneous group of disorders caused by mutations on the β-globin gene that result in the reduced or non production of β-globin chains. We report a rare β-globin mutation, IVS-II-848 (C>A) (: c.316-3C>A), which was found in a female Syrian patient. This mutation was associated with the IVS-I-1 (G>A) (: c.92+1G>A) mutation, and the genotype is a compound heterozygote for IVS-I-1(G>A)/IVS-II-848(C>A). This combination was found for the first time in Syria.
β地中海贫血(β-thal)是一组由β珠蛋白基因突变引起的遗传性异质性疾病,这些突变导致β珠蛋白链产生减少或不产生。我们报告了在一名叙利亚女性患者中发现的一种罕见的β珠蛋白突变,即IVS-II-848(C>A)(: c.316-3C>A)。该突变与IVS-I-1(G>A)(: c.92+1G>A)突变相关,其基因型为IVS-I-1(G>A)/IVS-II-848(C>A)的复合杂合子。这种组合在叙利亚首次被发现。